Qizhi Jieyu Pill for the Treatment of Cerebral Infarction During the Recovery Phase: Protocol for a Randomized Controlled Clinical Trial
BackgroundCerebral infarction, a life-threatening neurodegenerative disease, is one of the leading causes of disability and death. The recovery phase is a critical period for patients to regain cognitive ability, memory, and motor functions and to improve their ability to per...
Saved in:
| Main Authors: | Xuedong An, Liangqing Yu, Yuqin Ma, Junwei Zhang, Shiping Guo, Jilong Xu, Ping Zhao, Hongyan Xu, Feng Gao, Xueqin Wu, Yanlan Gao, Yao Jiang, Yali Liu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
JMIR Publications
2025-08-01
|
| Series: | JMIR Research Protocols |
| Online Access: | https://www.researchprotocols.org/2025/1/e75982 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cerebral Vasculitis and Diet Pills
by: J Gordon Millichap
Published: (1989-05-01) -
A systematic review and meta-analysis of shugan jieyu capsule combined with escitalopram in the treatment of senile depression
by: Xing Tang, et al.
Published: (2025-07-01) -
The impact of periodic leg movements during sleep on neurological recovery in patients with acute mild cerebral infarction
by: Shutong Sun, et al.
Published: (2025-08-01) -
Jinkui Shenqi Pill Combined with Pelvic Floor Biofeedback in Treatment of Postpartum Stress Urinary Incontinence with Kidney-yang Deficiency
by: Xueqin MIAO, et al.
Published: (2021-06-01) -
L-Arginine pill induced esophageal ulcer: causes not reported previously esophagitis for pills
by: Blanca Gallego Pérez, et al.
Published: (2014-11-01)